Literature DB >> 12010759

Site-specific modulation of LPS-induced fever and interleukin-1 beta expression in rats by interleukin-10.

Annemarie Ledeboer1, Rob Binnekade, John J P Brevé, John G J M Bol, Fred J H Tilders, Anne-Marie Van Dam.   

Abstract

Bacterial lipopolysaccharide (LPS) induces fever that is mediated by pyrogenic cytokines such as interleukin (IL)-1 beta. We hypothesized that the anti-inflammatory cytokine IL-10 modulates the febrile response to LPS by suppressing the production of pyrogenic cytokines. In rats, intravenous but not intracerebroventricular infusion of IL-10 was found to attenuate fever induced by peripheral administration of LPS (10 microg/kg iv). IL-10 also suppressed LPS-induced IL-1 beta production in peripheral tissues and in the brain stem. In contrast, central administration of IL-10 attenuated the febrile response to central LPS (60 ng/rat icv) and decreased IL-1 beta production in the hypothalamus and brain stem but not in peripheral tissues and plasma. Furthermore, intravenous LPS upregulated expression of IL-10 receptor (IL-10R1) mRNA in the liver, whereas intracerebroventricular LPS enhanced IL-10R1 mRNA in the hypothalamus. We conclude that IL-10 modulates the febrile response by acting in the periphery or in the brain dependent on the primary site of inflammation and that its mechanism of action most likely involves inhibition of local IL-1 beta production.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010759     DOI: 10.1152/ajpregu.00766.2001

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  13 in total

1.  Critical role for peripherally-derived interleukin-10 in mediating the thermoregulatory manifestations of fever and hypothermia in severe forms of lipopolysaccharide-induced inflammation.

Authors:  Lois M Harden; Christoph Rummel; Helen P Laburn; Jelena Damm; Florian Wiegand; Stephen Poole; Rüdiger Gerstberger; Joachim Roth
Journal:  Pflugers Arch       Date:  2013-10-10       Impact factor: 3.657

2.  Upregulation of CBLL1 in rat brain cortex after lipopolysaccharide treated.

Authors:  Maohong Cao; Heyi Zheng; Xiang Tan; Wei Xu; Ying Rui; Lei Li; Xiaofei Liu; Guangfei Xu; Gang Cui; Jian Xu; Jianhua Cao; Kaifu Ke; Qiyun Wu
Journal:  J Mol Histol       Date:  2012-11-17       Impact factor: 2.611

3.  Endogenous interleukin-10 is required for the defervescence of fever evoked by local lipopolysaccharide-induced and Staphylococcus aureus-induced inflammation in rats.

Authors:  T Cartmell; C Ball; A F Bristow; D Mitchell; S Poole
Journal:  J Physiol       Date:  2003-04-11       Impact factor: 5.182

4.  Hypoxia-inducible factor-1alpha protects cultured cortical neurons from lipopolysaccharide-induced cell death via regulation of NR1 expression.

Authors:  Shiu-Hwa Yeh; Jan-Jong Hung; Po-Wu Gean; Wen-Chang Chang
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

5.  Spinal glia modulate both adaptive and pathological processes.

Authors:  Elisabeth G Vichaya; Kyle M Baumbauer; Luis M Carcoba; James W Grau; Mary W Meagher
Journal:  Brain Behav Immun       Date:  2009-05-10       Impact factor: 7.217

Review 6.  Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.

Authors:  Hymie Anisman
Journal:  J Psychiatry Neurosci       Date:  2009-01       Impact factor: 6.186

7.  Upregulation of PRDM5 Is Associated with Astrocyte Proliferation and Neuronal Apoptosis Caused by Lipopolysaccharide.

Authors:  Yu Zhang; Xiaojuan Liu; Huaqing Xue; Xiaorong Liu; Aihua Dai; Yan Song; Kaifu Ke; Maohong Cao
Journal:  J Mol Neurosci       Date:  2016-04-13       Impact factor: 3.444

8.  Interleukin-10 modulates the synthesis of inflammatory mediators in the sensory circumventricular organs: implications for the regulation of fever and sickness behaviors.

Authors:  Lois M Harden; Christoph Rummel; Giamal N Luheshi; Stephen Poole; Rüdiger Gerstberger; Joachim Roth
Journal:  J Neuroinflammation       Date:  2013-02-06       Impact factor: 8.322

9.  Differential response of primary alveolar type I and type II cells to LPS stimulation.

Authors:  Mandi H Wong; Meshell D Johnson
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

10.  Interleukin-10 deficiency exacerbates inflammation-induced tau pathology.

Authors:  Lea L Weston; Shanya Jiang; Devon Chisholm; Lauren L Jantzie; Kiran Bhaskar
Journal:  J Neuroinflammation       Date:  2021-07-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.